I found this article pretty interesting. While it doesn't say anything about Leronlimab specifically, the whole article talks about researchers looking into inflammation as a cause of depression, MS, Alzheimer's, Parkinson's, and schizophrenia. Knowing Leronlimab's success as an anti-inflammatory (with no serious side affects), it really makes you wonder, if given the time and money for trials, Leronlimab could show promise in these indications. The more we find out about our "wonder drug", the more it makes me agree with some posters that stated a while back that we should all be taking a monthly does of Leronlimab...

https://getpocket.com/explore/item/from-depre...ket-newtab